Trial Profile
A phase II study to evaluate the efficacy, safety and tolerability of a switch maintenance treatment of vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Vinorelbine (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 05 Apr 2016 New trial record